Andrii Gavrylenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrii Gavrylenko has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Dmytro Masiuk
Dnipro State Agrarian and Economic University, Serhii Efremov Str., 25, Dnipro, 49600, Ukraine
3 shared publications
Latest Publications
- 1 February 2026
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in The Animal Biology
- Vol. 27 (4) , 30-35
The effect of organic acids mixture in the form of glycerids on the regulation of intestinal barrier function in piglets using SCFA-M: analysis of molecular markers
The functions of the intestinal system are crucial for animal health and productivity, as they ensure digestion, nutrient absorption, immune homeostasis, and microbiota regulation. Molecular markers of the intestinal system, such as occludin (OCL), fibronectin (FN), interferons (IFN-α, IFN-γ), and caspase-3 (Casp-3), serve as sensitive indicators of its functional state. This article presents the results of an experimental study on the effects of short-chain fatty acids (SCFA-M, C3-C12) on the expression of molecular markers of intestinal barrier function in three-way crossbred piglets. A total of 100 piglets aged 42 days were selected for the study and divided into control and experimental groups. The diet of the experimental group was supplemented with SCFA-M. Expression levels of molecular markers were assessed in the duodenum using the Western blot method. Obtained results showed a significant increase in the expression of OCL, FN, and IFN-α in the experimental group, indicating improved barrier function, extracellular matrix stability, and immune response. Specifically, by day 56, FN expression increased by 46.80 % (P<0.001), OCL by 16.78 % (P<0.001), and IFN-α by 20.06 % (P<0.05) compared to the control group. Contrary, decreased levels of IFN-γ and Casp-3 indicated reduced inflammation and apoptotic activity. The correlations between molecular marker expression and metabolic parameters were analysed to clarify the interaction of these indices. Notably, in 56-day-old piglets of the control group, OCL expression negatively correlated with blood total protein levels (r = −0.83; P<0.05). In 77-day-old animals of the experimental group, correlations were found between FN and OCL expression and serum calcium levels (r = −0.90; P<0.05). These findings demonstrated the positive effects of SCFA-M on immune regulation, proinflammatory balance, and the maintenance of intestinal barrier integrity in piglets. The presented data may be applied in veterinary practice for the prevention of intestinal infections, enhancement of pathogen resistance, and optimization of animal productivity.
- 1 February 2026
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in The Animal Biology
- Vol. 27 (4) , 30-35
The effect of organic acids mixture in the form of glycerids on the regulation of intestinal barrier function in piglets using SCFA-M: analysis of molecular markers
The functions of the intestinal system are crucial for animal health and productivity, as they ensure digestion, nutrient absorption, immune homeostasis, and microbiota regulation. Molecular markers of the intestinal system, such as occludin (OCL), fibronectin (FN), interferons (IFN-α, IFN-γ), and caspase-3 (Casp-3), serve as sensitive indicators of its functional state. This article presents the results of an experimental study on the effects of short-chain fatty acids (SCFA-M, C3-C12) on the expression of molecular markers of intestinal barrier function in three-way crossbred piglets. A total of 100 piglets aged 42 days were selected for the study and divided into control and experimental groups. The diet of the experimental group was supplemented with SCFA-M. Expression levels of molecular markers were assessed in the duodenum using the Western blot method. Obtained results showed a significant increase in the expression of OCL, FN, and IFN-α in the experimental group, indicating improved barrier function, extracellular matrix stability, and immune response. Specifically, by day 56, FN expression increased by 46.80 % (P<0.001), OCL by 16.78 % (P<0.001), and IFN-α by 20.06 % (P<0.05) compared to the control group. Contrary, decreased levels of IFN-γ and Casp-3 indicated reduced inflammation and apoptotic activity. The correlations between molecular marker expression and metabolic parameters were analysed to clarify the interaction of these indices. Notably, in 56-day-old piglets of the control group, OCL expression negatively correlated with blood total protein levels (r = −0.83; P<0.05). In 77-day-old animals of the experimental group, correlations were found between FN and OCL expression and serum calcium levels (r = −0.90; P<0.05). These findings demonstrated the positive effects of SCFA-M on immune regulation, proinflammatory balance, and the maintenance of intestinal barrier integrity in piglets. The presented data may be applied in veterinary practice for the prevention of intestinal infections, enhancement of pathogen resistance, and optimization of animal productivity.
- Open Access
- 25 December 2025
- Published by Stepan Gzhytskyi National University of Veterinary Medicine and Biotechnologies Lviv in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
- Vol. 27 (120) , 98-108
Modulation of the piglet large intestine microbiome under the influence of monoglycerides
The study examined the effects of SCFA-M, a short-chain fatty acid-based supplement, on the gut microbiome composition of piglets. For the experiment, piglets were divided into control and experimental groups, with the latter receiving SCFA-M throughout the study. The microbial populations in the cecum, colon, and rectum were analyzed at different stages using microbiological culture methods and quantitative assessments. The results revealed significant changes in the gut microbiota composition of the experimental group. SCFA-M reduced the abundance of potentially pathogenic bacteria such as Escherichia coli and Staphylococcus spp. in the cecum, colon, and rectum, while promoting a stable increase in beneficial bacteria, particularly Enterococcus spp. Specifically, the abundance of E. coli in the cecum decreased by 88 % by day 77, and the levels of Staphylococcus spp. dropped by 68.6 % compared to the control group. Conversely, the abundance of Enterococcus spp. in the experimental group was 36.1 % higher, indicating its potential to support a healthy gut microbiome. Similar trends were observed in the colon, where SCFA-M effectively reduced E. coli levels and stabilized Enterococcus spp., increasing their abundance by 77.8 % compared to the control group. In the rectum, Enterococcus spp. dominated, with their abundance increasing by 39.9 % compared to the control group on day 77, while E. coli levels gradually decreased throughout the study. The supplement exhibited a strong antibacterial effect, as evidenced by the high negative correlations between E. coli and Staphylococcus spp. across different gut sections. These results highlight the potential of SCFA-M to modulate the gut microbiome by reducing pathogenic bacteria and enhancing beneficial taxa, offering a promising approach to improving the gut health of young animals. Further research is recommended to explore broader applications and the mechanisms of the supplement's action.
- 25 December 2025
- Published by Stepan Gzhytskyi National University of Veterinary Medicine and Biotechnologies Lviv in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
- Vol. 27 (120) , 98-108
Open AccessModulation of the piglet large intestine microbiome under the influence of monoglycerides
The study examined the effects of SCFA-M, a short-chain fatty acid-based supplement, on the gut microbiome composition of piglets. For the experiment, piglets were divided into control and experimental groups, with the latter receiving SCFA-M throughout the study. The microbial populations in the cecum, colon, and rectum were analyzed at different stages using microbiological culture methods and quantitative assessments. The results revealed significant changes in the gut microbiota composition of the experimental group. SCFA-M reduced the abundance of potentially pathogenic bacteria such as Escherichia coli and Staphylococcus spp. in the cecum, colon, and rectum, while promoting a stable increase in beneficial bacteria, particularly Enterococcus spp. Specifically, the abundance of E. coli in the cecum decreased by 88 % by day 77, and the levels of Staphylococcus spp. dropped by 68.6 % compared to the control group. Conversely, the abundance of Enterococcus spp. in the experimental group was 36.1 % higher, indicating its potential to support a healthy gut microbiome. Similar trends were observed in the colon, where SCFA-M effectively reduced E. coli levels and stabilized Enterococcus spp., increasing their abundance by 77.8 % compared to the control group. In the rectum, Enterococcus spp. dominated, with their abundance increasing by 39.9 % compared to the control group on day 77, while E. coli levels gradually decreased throughout the study. The supplement exhibited a strong antibacterial effect, as evidenced by the high negative correlations between E. coli and Staphylococcus spp. across different gut sections. These results highlight the potential of SCFA-M to modulate the gut microbiome by reducing pathogenic bacteria and enhancing beneficial taxa, offering a promising approach to improving the gut health of young animals. Further research is recommended to explore broader applications and the mechanisms of the supplement's action.
- Open Access
- 16 December 2024
- Published by Dnipro State Agrarian and Economic University in Theoretical and Applied Veterinary Medicine
- Vol. 12 (4) , 21-30
Monoglyceride supplementation modulates microbiom of small intestine in piglets
Intestinal function maintenence in productive animals remains one of the key task of current pig farming. Given the requirements for limiting the use of antibiotics, the development of alternative strategies is an urgent issue for maintaining the profitability of the industry. The study of the short-chain fatty acids with monoglycerides (SCFAM) blend exposure to microbiome composition was carried out using weaned piglets from 42 to 77 days of age. The SCFAM-exposed group of piglets exposed to SCFAM in a dose 1 kg per ton of the feed. The effect of SCFAM on the microbiome composition were assessed through the measuring the content of Escherichia coli, Staphylococcus spp., and Enterococcus spp. in three duodenum, jejunum, and ileum individual sections of the small intestine. The treatment with SCFAM significantly downregulated the content of E. coli in all studied sections of the small intestine of piglets in the SCFAM-exposed group. The most significant decrease in E. coli was observed in the ileum on the 56th day of life. Similar to the aforementioned SCFAM effect on the E. coli content, but slightly different changes in the content of Staphylococcus spp. were determined in all studied small intestine sections in the SCFAM-exposed groups on the 56th and 77th day of life. A progressive increase in the content of Staphylococcus spp. was detected on the 77th day compared to that on the 56th day of life. At the same time, the determination of the level of Enterococcus spp. showed significant differences in the bifurcation changes in the content of this taxon in the control and corresponding SCFAM-exposed groups, where the increase in the control group on the 56th day of life was accompanied by a decrease in it in the SCFAM-exposed group. Despite individual differences, in general, the observed effect of the use of SCFAM was linked to the growth suppression of the both pathogen taxon Staphylococcus spp. and commensal taxa E. coli and Enterococcus spp. The results of the correlation analysis has showed that the decrease in the content of E. coli, Staphylococcus spp. and Enterococcus spp. and 2-week consumption of SCFAM by piglets in the SCFAM-exposed group on day 56 exhibit a high level of correlation coefficient. The results of present study demonstrated the promising SCFAM potential for its application in swine farming to protect a stable microbiota composition, intestinal health, and reduce the level of microflora pathogenes in piglets.
- 16 December 2024
- Published by Dnipro State Agrarian and Economic University in Theoretical and Applied Veterinary Medicine
- Vol. 12 (4) , 21-30
Open AccessMonoglyceride supplementation modulates microbiom of small intestine in piglets
Intestinal function maintenence in productive animals remains one of the key task of current pig farming. Given the requirements for limiting the use of antibiotics, the development of alternative strategies is an urgent issue for maintaining the profitability of the industry. The study of the short-chain fatty acids with monoglycerides (SCFAM) blend exposure to microbiome composition was carried out using weaned piglets from 42 to 77 days of age. The SCFAM-exposed group of piglets exposed to SCFAM in a dose 1 kg per ton of the feed. The effect of SCFAM on the microbiome composition were assessed through the measuring the content of Escherichia coli, Staphylococcus spp., and Enterococcus spp. in three duodenum, jejunum, and ileum individual sections of the small intestine. The treatment with SCFAM significantly downregulated the content of E. coli in all studied sections of the small intestine of piglets in the SCFAM-exposed group. The most significant decrease in E. coli was observed in the ileum on the 56th day of life. Similar to the aforementioned SCFAM effect on the E. coli content, but slightly different changes in the content of Staphylococcus spp. were determined in all studied small intestine sections in the SCFAM-exposed groups on the 56th and 77th day of life. A progressive increase in the content of Staphylococcus spp. was detected on the 77th day compared to that on the 56th day of life. At the same time, the determination of the level of Enterococcus spp. showed significant differences in the bifurcation changes in the content of this taxon in the control and corresponding SCFAM-exposed groups, where the increase in the control group on the 56th day of life was accompanied by a decrease in it in the SCFAM-exposed group. Despite individual differences, in general, the observed effect of the use of SCFAM was linked to the growth suppression of the both pathogen taxon Staphylococcus spp. and commensal taxa E. coli and Enterococcus spp. The results of the correlation analysis has showed that the decrease in the content of E. coli, Staphylococcus spp. and Enterococcus spp. and 2-week consumption of SCFAM by piglets in the SCFAM-exposed group on day 56 exhibit a high level of correlation coefficient. The results of present study demonstrated the promising SCFAM potential for its application in swine farming to protect a stable microbiota composition, intestinal health, and reduce the level of microflora pathogenes in piglets.